高通量泪液蛋白质组学揭示甲状腺眼病多层面分子特征
该研究用Schirmer试纸采集20例甲状腺眼病(TED)、20例无眼部受累的Graves病(GD)和14例健康对照的泪液,采用PCT-PulseDIA-MS workflow定量5966种泪液蛋白。由CANT1、IGFBP7和CASP14组成的三蛋白panel区分TED与GD的AUC达0.971。
要点
- 眼病相关差异蛋白富集于免疫调节、脂代谢、血管功能和细胞外基质重塑。
- CANT1、IGFBP7、CASP14三蛋白panel区分TED与GD的AUC为0.971。
核心结论
- 泪液蛋白质组学揭示TED发病过程中眼病、自身免疫和甲状腺功能亢进共同塑造的分子特征。
- 泪液蛋白有潜力作为TED早期、无创的诊断生物标志物。
研究设计与样本
- 收集20例TED、20例无眼部受累GD和14例健康对照的泪液样本,使用Schirmer试纸。
- 采用PCT-PulseDIA-MS workflow进行蛋白质组学分析。
主要发现
- 共定量5966种泪液蛋白,TED组泪液蛋白质组改变最广泛。
- 眼病相关差异蛋白富集于免疫调节、脂代谢、血管功能和细胞外基质重塑。
- 多种关键差异蛋白与临床、实验室和影像学变量显著相关。
关键数值与推荐
- 三蛋白panel(CANT1、IGFBP7、CASP14)区分TED与GD的AUC为0.971。
临床怎么用
- 泪液蛋白质组学可作为TED无创诊断和机制研究的潜在工具。
- CANT1、IGFBP7、CASP14三蛋白panel有望辅助区分TED与GD,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thyroid eye disease (TED) is the most common extrathyroidal manifestation of Graves' disease (GD). Despite its clinical significance, the pathogenic mechanisms and reliable diagnostic biomarkers for TED remain incompletely defined. Tear fluid offers a noninvasive window into disease-related molecular changes. METHODS: Tear samples were collected using Schirmer strips from 20 patients with TED, 20 patients with GD without ocular involvement, and 14 healthy controls (HCs). Proteomic profiling was performed using a novel pressure cycling technology-pulse data-independent acquisition mass spectrometry (PCT-PulseDIA-MS) workflow. RESULTS: A total of 5966 tear proteins were quantified. Differentially expressed proteins (DEPs) were identified through pairwise group comparisons. Patients with TED showed the most extensive tear proteomic alterations among the studied groups. One hundred seventy-four DEPs were associated with ophthalmopathy, 14 with autoimmunity, and 13 with hyperthyroidism. The ophthalmopathy-related DEPs were enriched in immune regulation, lipid metabolism, vascular function, and extracellular matrix remodeling. Several key DEPs showed significant correlations with clinical, laboratory, and imaging variables. A three-protein panel comprising calcium-activated nucleotidase 1 (CANT1), insulin-like growth factor-binding protein 7 (IGFBP7), and caspase 14 (CASP14) achieved excellent diagnostic performance in distinguishing TED from GD, with an area under the curve (AUC) of 0.971. CONCLUSIONS: Tear proteomics reveals distinct molecular signatures shaped by the combined influences of ophthalmopathy, autoimmunity, and hyperthyroidism throughout the pathogenesis of TED, underscoring the potential of tear proteins as early, noninvasive biomarkers for disease diagnosis.
引用
- Li R, Zhang H, Yang L, et al. High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease. Invest Ophthalmol Vis Sci. 2025. PMID: 41196132. doi:10.1167/iovs.66.14.11
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。